Insulet | PODD - Creditori Commerciali





Creditori Commerciali Cambiamento Data
Abbott USD 4.68B 439M 2026-03
Align Technology USD 117.88M 8.04M 2026-09
AtriCure USD 80.24M 1.5M 2026-09
Baxter International USD 1.02B 10M 2026-09
Becton, Dickinson and Co. USD 6.11B 173M 2026-06
Boston Scientific USD 1.25B 19M 2026-09
Cardinal Health USD 40.94B 2.65B 2026-09
Cooper Companies USD 251.2M 17.9M 2026-06
Dexcom USD 2.08B 134.8M 2026-06
Edwards Lifesciences USD 199.7M 10.8M 2026-09
Eli Lilly USD 5.79B 319M 2026-09
Globus Medical USD 107.43M 487K 2026-09
ICU Medical USD 142.99M 6.18M 2026-09
Inogen USD 21.22M 684K 2025-09
Insulet USD 162.2M 38.9M 2026-09
Integra LifeSciences USD 82.64M 5.31M 2026-06
J&J USD 9.32B 94M 2026-09
Medtronic USD 2.7B 51M 2026-06
Merit Medical Systems USD 70.74M 2.88M 2026-06
Roche Holding CHF 5.54B 237M 2026-06
Solventum Corp USD 808M 107M 2026-09
Stryker USD 1.66B 71M 2026-06
Tandem Diabetes Care USD 74.8M 10.67M 2026-09
Teleflex USD 142.87M 423K 2026-09
West Pharmaceutical Services USD 249.4M 3.3M 2026-09
Zimmer Biomet Holdings USD 357.5M 5.1M 2026-09